Pfizer beats earnings estimates as declining Covid business performs better than expected

Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021.Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit, as the company slashed costs while demand for its Covid products plummeted.The company reversed roughly $3.5 billion in revenue related to the expected return of 6.5 ...